Delivery of neurotrophic factors to neuronal targets: toward gene therapy in the CNS.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Drug News and Perspectives

• Publication date

  2000-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 12937641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic benefit of ciliary neurotrophic factor in progressive motor neuronopathy depends on the route of delivery

  1999cited by this paper
• Viral receptors and vector purification: New approaches for generating clinical-grade reagents

  1999cited by this paper
• Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration.

  1999cited by this paper
• Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy.

  1999cited by this paper
• Transplants of Fibroblasts Genetically Modified to Express BDNF Promote Regeneration of Adult Rat Rubrospinal Axons and Recovery of Forelimb Function

  1999cited by this paper
• Nerve growth factor–hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1

  1999cited by this paper
• Leukemia Inhibitory Factor Augments Neurotrophin Expression and Corticospinal Axon Growth after Adult CNS Injury

  1999cited by this paper
• Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain.

  1999cited by this paper
• A controlled trial of recombinant methionyl human BDNF in ALS

  1999cited by this paper
• Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease

  1998cited by this paper
• Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination.

  1998cited by this paper
• Neurturin Exerts Potent Actions on Survival and Function of Midbrain Dopaminergic Neurons

  1998cited by this paper
• Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors.

  1998cited by this paper
• Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

  1998cited by this paper
• Permanent rescue of lesioned neonatal motoneurons and enhanced axonal regeneration by adenovirus‐mediated expression of glial cell‐line‐derived neurotrophic factor

  1998cited by this paper
• Functional Recovery and Enhanced Corticofugal Plasticity after Unilateral Pyramidal Tract Lesion and Blockade of Myelin-Associated Neurite Growth Inhibitors in Adult Rats

  1998cited by this paper
• Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions

  1998cited by this paper
• A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group.

  1998cited by this paper
• Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus

  1998cited by this paper
• Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord

  1998cited by this paper
• Persephin, a novel neurotrophic factor related to GDNF and neurturin.

  1998cited by this paper
• Anterograde Transport of Neurotrophin Proteins in the CNS - A Reassessment of the Neurotrophic Hypothesis

  1998cited by this paper
• Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells.

  1997cited by this paper
• Anterograde transport of brain-derived neurotrophic factor and its role in the brain

  1997cited by this paper
• Human Fetal Astrocytes as an Ex Vivo Gene Therapy Vehicle for Delivering Biologically Active Nerve Growth Factor

  1997cited by this paper
• Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector

  1997cited by this paper
• Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

  1997cited by this paper
• Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord.

  1997cited by this paper
• Reversible schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor

  1997cited by this paper
• Distribution of Brain-Derived Neurotrophic Factor (BDNF) Protein and mRNA in the Normal Adult Rat CNS: Evidence for Anterograde Axonal Transport

  1997cited by this paper
• Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.

  1997cited by this paper
• GDNF Reduces Drug-Induced Rotational Behavior after Medial Forebrain Bundle Transection by a Mechanism Not Involving Striatal Dopamine

  1997cited by this paper
• Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord

  1997cited by this paper
• Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors

  1997cited by this paper
• Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons

  1997cited by this paper
• Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease

  1997cited by this paper
• Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy

  1997cited by this paper
• Gene transfer by adeno-associated virus vectors into the central nervous system.

  1997cited by this paper
• Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.

  1997cited by this paper
• Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells.

  1997cited by this paper
• Cellular Delivery of Neurotrophin-3 Promotes Corticospinal Axonal Growth and Partial Functional Recovery after Spinal Cord Injury

  1997cited by this paper
• Fetal spinal cord transplants rescue some axotomized rubrospinal neurons from retrograde cell death in adult rats.

  1997cited by this paper
• Prevention of motoneuron death by adenovirus‐mediated neurotrophic factors

  1997cited by this paper
• Grafts of EGF‐responsive neural stem cells derived from GFAP‐hNGF transgenic mice: Trophic and tropic effects in a rodent model of Huntington's disease

  1997cited by this paper
• Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons.

  1997cited by this paper
• Recombinant human insulin-like growth factor-I in ALS: description of a double-blind, placebo-controlled study. North American ALS/IGF-I Study Group.

  1996cited by this paper
• Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury.

  1996cited by this paper
• Functional recovery in parkinsonian monkeys treated with GDNF

  1996cited by this paper
• Protection of the Neostriatum against Excitotoxic Damage by Neurotrophin-Producing, Genetically Modified Neural Stem Cells

  1996cited by this paper
• Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients

  1996cited by this paper
• Direct intracerebral nerve growth factor gene transfer using a recombinant adenovirus: effect on basal forebrain cholinergic neurons during aging.

  1996cited by this paper
• Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts.

  1996cited by this paper
• Immunological Instability of Persistent Adenovirus Vectors in the Brain: Peripheral Exposure to Vector Leads to Renewed Inflammation, Reduced Gene Expression, and Demyelination

  1996cited by this paper
• Implants of Encapsulated Human CNTF-Producing Fibroblasts Prevent Behavioral Deficits and Striatal Degeneration in a Rodent Model of Huntington’s Disease

  1996cited by this paper
• A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group.

  1996cited by this paper
• Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model.

  1996cited by this paper
• Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration.

  1996cited by this paper
• Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons.

  1996cited by this paper
• Gene Therapy for Amyotrophic Lateral Sclerosis (ALS) Using a Polymer Encapsulated Xenogenic Cell Line Engineered to Secrete hCNTF. Lausanne University Medical School, Lausanne, Switzerland

  1996cited by this paper
• Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

  1996cited by this paper
• Spinal Cord Repair in Adult Paraplegic Rats: Partial Restoration of Hind Limb Function

  1996cited by this paper
• Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration.

  1996cited by this paper
• A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis

  1996cited by this paper
• A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord.

  1995cited by this paper
• Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease

  1995cited by this paper
• TGF‐beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity.

  1995cited by this paper
• Essential role of neocortical acetylcholine in spatial memory

  1995cited by this paper
• Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors

  1995cited by this paper
• Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration

  1995cited by this paper
• Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease.

  1995cited by this paper
• Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF

  1995cited by this paper
• Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

  1995cited by this paper
• Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor.

  1995cited by this paper
• CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: complete rescue of axotomized cholinergic neurons after transplantation into the septum

  1995cited by this paper
• Polymer Encapsulated Cell Lines Genetically Engineered to Release Ciliary Neurotrophic Factor Can Slow Down Progressive Motor Neuronopathy in the Mouse

  1995cited by this paper
• Histometric effects of ciliary neurotrophic factor in wobbler mouse motor neuron disease

  1995cited by this paper
• Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

  1995cited by this paper
• Axonal regeneration into Schwann cell‐seeded guidance channels grafted into transected adult rat spinal cord

  1995cited by this paper
• Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain.

  1995cited by this paper
• Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum.

  1994cited by this paper
• The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease

  1994cited by this paper
• Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

  1994cited by this paper
• Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells.

  1994cited by this paper
• The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor.

  1994cited by this paper
• New approaches to drug delivery through the blood-brain barrier.

  1994cited by this paper
• Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants.

  1994cited by this paper
• Neurotrophin 4/5 is a trophic factor for mammalian facial motor neurons.

  1994cited by this paper
• Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord.

  1994cited by this paper
• Implants of polymer‐encapsulated human NGF‐secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons

  1994cited by this paper
• Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion

  1994cited by this paper
• Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon

  1994cited by this paper
• Schwann cells induce sprouting in motor and sensory axons in the adult rat spinal cord

  1994cited by this paper
• Members of several gene families influence survival of rat motoneurons in vitro and in vivo

  1993cited by this paper
• Sprouting and Regeneration of Lesioned Corticospinal Tract Fibres in the Adult Rat Spinal Cord

  1993cited by this paper
• GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

  1993cited by this paper
• The neurotrophic factor concept: a reexamination

  1993cited by this paper
• Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum.

  1993cited by this paper
• Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions

  1993cited by this paper
• Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo.

  1993cited by this paper
• Recovery of function after spinal cord injury: mechanisms underlying transplant-mediated recovery of function differ after spinal cord injury in newborn and adult rats.

  1993cited by this paper

• Role of Gigaxonin in the Regulation of Intermediate Filaments: a Study Using Giant Axonal Neuropathy Patient-Derived Induced Pluripotent Stem Cell-Motor Neurons

  2013cites this paper
• Gene therapy approaches to ataxias.

  2009cites this paper
• Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications

  2008cites this paper
• Nerve replacement strategies for cavernous nerves.

  2005cites this paper